{"entity":{"type":"insider","cik":"0001380186","url":"/insider/0001380186","json_url":"/insider/0001380186.json","name":"Keese Kyle","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":57,"n_filings":16,"first":"2007-05-31","last":"2010-08-25","span_basis":"filed_date"},"name_variants":[{"name":"Keese Kyle","source":"filing","n_filings":16,"first_seen":"2007-05-31","last_seen":"2010-08-25"}],"transactions":[{"id":7503633,"accession":"0001140361-10-034940","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-034940","line_url":"/filing/0001140361-10-034940#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Mfg Ops)","role_mark":"O","role_mark_label":"Officer (SVP, Mfg Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Mfg Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5276.0,"shares_display":"5,276","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":92330.0,"total_display":"92,330.00","total_whole":"92,330","shares_owned_after":9070.0,"shares_owned_after_display":"9,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-18","filed_date":"2010-08-25","scope":"insider"},{"id":5731371,"accession":"0001367644-09-000068","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001367644-09-000068","line_url":"/filing/0001367644-09-000068#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Mfg Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Mfg Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Mfg Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":336.0,"shares_owned_after_display":"336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-15","filed_date":"2009-09-28","scope":"insider"},{"id":3631611,"accession":"0001367644-08-000087","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001367644-08-000087","line_url":"/filing/0001367644-08-000087","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Manufacturing Ops)","role_mark":"O","role_mark_label":"Officer (SVP, Manufacturing Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Manufacturing Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9900.0,"shares_display":"9,900","price_per_share":20.11030303030303,"price_display":"20.11","price_state":"stated","total_value":199092.0,"total_display":"199,092.00","total_whole":"199,092","shares_owned_after":8896.0,"shares_owned_after_display":"8,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-11","filed_date":"2008-11-12","scope":"insider","n_lines":30},{"id":3602957,"accession":"0001367644-08-000088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001367644-08-000088","line_url":"/filing/0001367644-08-000088#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Manufacturing Ops)","role_mark":"O","role_mark_label":"Officer (SVP, Manufacturing Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Manufacturing Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.34,"price_display":"20.34","price_state":"stated","total_value":2034.0,"total_display":"2,034.00","total_whole":"2,034","shares_owned_after":196.0,"shares_owned_after_display":"196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-11","filed_date":"2008-11-12","scope":"insider"},{"id":7991585,"accession":"0001367644-07-000096","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001367644-07-000096","line_url":"/filing/0001367644-07-000096#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":9.93,"price_display":"9.93","price_state":"stated","total_value":12412.5,"total_display":"12,412.50","total_whole":"12,413","shares_owned_after":7316.0,"shares_owned_after_display":"7,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-29","filed_date":"2007-07-02","scope":"insider"},{"id":7991582,"accession":"0001367644-07-000096","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001367644-07-000096","line_url":"/filing/0001367644-07-000096#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1446.0,"shares_display":"1,446","price_per_share":9.69,"price_display":"9.69","price_state":"stated","total_value":14011.74,"total_display":"14,011.74","total_whole":"14,012","shares_owned_after":7121.0,"shares_owned_after_display":"7,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-28","filed_date":"2007-07-02","scope":"insider"},{"id":7283813,"accession":"0001367644-07-000093","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001367644-07-000093","line_url":"/filing/0001367644-07-000093#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1445.0,"shares_display":"1,445","price_per_share":9.58,"price_display":"9.58","price_state":"stated","total_value":13843.1,"total_display":"13,843.10","total_whole":"13,843","shares_owned_after":7121.0,"shares_owned_after_display":"7,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-27","filed_date":"2007-06-28","scope":"insider"},{"id":7283806,"accession":"0001367644-07-000093","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001367644-07-000093","line_url":"/filing/0001367644-07-000093#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1445.0,"shares_display":"1,445","price_per_share":9.36,"price_display":"9.36","price_state":"stated","total_value":13525.2,"total_display":"13,525.20","total_whole":"13,525","shares_owned_after":7121.0,"shares_owned_after_display":"7,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-26","filed_date":"2007-06-28","scope":"insider"},{"id":8072921,"accession":"0001367644-07-000087","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001367644-07-000087","line_url":"/filing/0001367644-07-000087#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1451.0,"shares_display":"1,451","price_per_share":9.16,"price_display":"9.16","price_state":"stated","total_value":13291.16,"total_display":"13,291.16","total_whole":"13,291","shares_owned_after":7121.0,"shares_owned_after_display":"7,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-25","filed_date":"2007-06-26","scope":"insider"},{"id":8072912,"accession":"0001367644-07-000087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001367644-07-000087","line_url":"/filing/0001367644-07-000087#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":8.9,"price_display":"8.90","price_state":"stated","total_value":11570.0,"total_display":"11,570.00","total_whole":"11,570","shares_owned_after":7121.0,"shares_owned_after_display":"7,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-22","filed_date":"2007-06-26","scope":"insider"},{"id":8161165,"accession":"0001367644-07-000080","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001367644-07-000080","line_url":"/filing/0001367644-07-000080#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1316.0,"shares_display":"1,316","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":11844.0,"total_display":"11,844.00","total_whole":"11,844","shares_owned_after":6974.0,"shares_owned_after_display":"6,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-21","filed_date":"2007-06-22","scope":"insider"},{"id":8161163,"accession":"0001367644-07-000080","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001367644-07-000080","line_url":"/filing/0001367644-07-000080#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1336.0,"shares_display":"1,336","price_per_share":9.37,"price_display":"9.37","price_state":"stated","total_value":12518.32,"total_display":"12,518.32","total_whole":"12,518","shares_owned_after":6843.0,"shares_owned_after_display":"6,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-20","filed_date":"2007-06-22","scope":"insider"},{"id":6843756,"accession":"0001367644-07-000070","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001367644-07-000070","line_url":"/filing/0001367644-07-000070#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1405.0,"shares_display":"1,405","price_per_share":9.83,"price_display":"9.83","price_state":"stated","total_value":13811.15,"total_display":"13,811.15","total_whole":"13,811","shares_owned_after":6732.0,"shares_owned_after_display":"6,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-19","filed_date":"2007-06-20","scope":"insider"},{"id":6843750,"accession":"0001367644-07-000070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001367644-07-000070","line_url":"/filing/0001367644-07-000070#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1405.0,"shares_display":"1,405","price_per_share":10.07,"price_display":"10.07","price_state":"stated","total_value":14148.35,"total_display":"14,148.35","total_whole":"14,148","shares_owned_after":6690.0,"shares_owned_after_display":"6,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-18","filed_date":"2007-06-20","scope":"insider"},{"id":7127771,"accession":"0001169232-07-002693","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001169232-07-002693","line_url":"/filing/0001169232-07-002693#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1405.0,"shares_display":"1,405","price_per_share":9.39,"price_display":"9.39","price_state":"stated","total_value":13192.95,"total_display":"13,192.95","total_whole":"13,193","shares_owned_after":6648.0,"shares_owned_after_display":"6,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-15","filed_date":"2007-06-18","scope":"insider"},{"id":7127769,"accession":"0001169232-07-002693","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001169232-07-002693","line_url":"/filing/0001169232-07-002693#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1427.0,"shares_display":"1,427","price_per_share":8.55,"price_display":"8.55","price_state":"stated","total_value":12200.85,"total_display":"12,200.85","total_whole":"12,201","shares_owned_after":6606.0,"shares_owned_after_display":"6,606","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-14","filed_date":"2007-06-18","scope":"insider"},{"id":7662487,"accession":"0001367644-07-000063","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001367644-07-000063","line_url":"/filing/0001367644-07-000063#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3124.0,"shares_display":"3,124","price_per_share":8.51,"price_display":"8.51","price_state":"stated","total_value":26585.24,"total_display":"26,585.24","total_whole":"26,585","shares_owned_after":6606.0,"shares_owned_after_display":"6,606","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-13","filed_date":"2007-06-14","scope":"insider"},{"id":7662483,"accession":"0001367644-07-000063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001367644-07-000063","line_url":"/filing/0001367644-07-000063#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1545.0,"shares_display":"1,545","price_per_share":8.73,"price_display":"8.73","price_state":"stated","total_value":13487.85,"total_display":"13,487.85","total_whole":"13,488","shares_owned_after":5511.0,"shares_owned_after_display":"5,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-12","filed_date":"2007-06-14","scope":"insider"},{"id":7758255,"accession":"0001367644-07-000058","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001367644-07-000058","line_url":"/filing/0001367644-07-000058#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1545.0,"shares_display":"1,545","price_per_share":8.77,"price_display":"8.77","price_state":"stated","total_value":13549.65,"total_display":"13,549.65","total_whole":"13,550","shares_owned_after":5320.0,"shares_owned_after_display":"5,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-11","filed_date":"2007-06-12","scope":"insider"},{"id":7758251,"accession":"0001367644-07-000058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001367644-07-000058","line_url":"/filing/0001367644-07-000058#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1545.0,"shares_display":"1,545","price_per_share":8.46,"price_display":"8.46","price_state":"stated","total_value":13070.7,"total_display":"13,070.70","total_whole":"13,071","shares_owned_after":4395.0,"shares_owned_after_display":"4,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-08","filed_date":"2007-06-12","scope":"insider"},{"id":8161161,"accession":"0001367644-07-000051","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001367644-07-000051","line_url":"/filing/0001367644-07-000051#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380186","owner_name":"Keese Kyle","owner_display_name":"Keese Kyle","owner_url":"/insider/0001380186","role":"Officer (SVP, Corporate Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1529.0,"shares_display":"1,529","price_per_share":8.76,"price_display":"8.76","price_state":"stated","total_value":13394.04,"total_display":"13,394.04","total_whole":"13,394","shares_owned_after":4550.0,"shares_owned_after_display":"4,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-07","filed_date":"2007-06-08","scope":"insider"}],"collapsed":true,"next_cursor":"2007-06-07|8161161","ledger_fault":false,"count":{"value":57,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":57,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":57},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001367644","name":"Emergent BioSolutions Inc.","url":"/issuer/0001367644","role":"Officer (SVP, Mfg Ops)","n_filings":16,"first_seen":"2007-05-31","last_seen":"2010-08-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001380186","retrieved_at":"2026-08-23T20:56:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}